Novel inclusion complex enhances antimicrobial activity and stability in a novel formulation, suggesting wider applications.
• A novel LAE/HP-β-CD inclusion complex (IC) was prepared and fully characterized. • A partially included structure of the LAE/HP-β-CD IC has been elucidated. • The IC enhanced pH, thermal and cold storage stability of LAE. • The IC hindered the interactions between anionic components and LAE • The LAE/HP-β-CD IC could serve as a novel emulsifier and antimicrobial agent. Lauric arginate (LAE) has potent antimicrobial activity; however, it exhibits inadequate stability and antimicrobial efficacy due to interactions with anionic constituents. This study developed a novel LAE/hydroxypropyl-β-cyclodextrin inclusion complex (LAE/HP-β-CD IC), the structure of which was examined using various analytical techniques. The results showed that the non-polar tail of LAE likely penetrated the HP-β-CD cavity through its larger opening and exited through the narrower end, forming a partially included structure. The LAE/HP-β-CD IC effectively enhanced the thermal stability and emulsifying properties of LAE, extending its pH-stable range (1–9) and enabling stable storage for at least 35 d (4°C, pH 3–9). Moreover, it hindered the interactions between anionic components and LAE, enhancing its antimicrobial activity. The LAE/HP-β-CD IC significantly amplified the inhibition zone against Staphylococcus aureus from 15.54 to 31.64 mm and reduced the minimum inhibitory concentration of LAE against Escherichia coli from 0.038 to 0.020 mg/mL. This LAE/HP-β-CD IC is a promising novel emulsifying antimicrobial agent that could expand the application of LAE.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: